March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Defense & Aerospace Air Power Podcast: Global View
Podcast
In a week when airpower news came from every angle, Becca Wasser, CNAS adjunct senior fellow, was on top of it all. She leads defense research at Bloomberg Economics, and we c...
By Becca Wasser
-
Balance of Power: Powell Probe Sparks GOP Backlash
Podcast
President Donald Trump faced rare opposition from key Republican lawmakers after Federal Reserve Chair Jerome Powell accused the Department of Justice of launching a grand jur...
By Becca Wasser
-
The Venezuela Blockade
Commentary
Roxanna Vigil, Council on Foreign Relations International Affairs Fellow, talks about President Donald Trump's order to blockade sanctioned oil tankers in Venezuela, and the r...
By Becca Wasser
-
The Astronomical Cost of Defeating ‘Any Foreign Aerial Attack’
Video
Building Trump’s proposed missile and air defense system would be an enormous task — and the president’s spending target is likely just a fraction of the final price. CNAS adj...
By Becca Wasser
